Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–17 of 17 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT06586957
- Conditions
- Adnexal Diseases, Advanced Endometrial Carcinoma, Advanced Gastric Carcinoma, +62 more
- Locations
-
- University of Arkansas Medical School Little Rock, Arkansas, United States
- University of California - Los Angeles Los Angeles, California, United States
- UCSF San Francisco, California, United States
- SCRI at HealthOne Denver, Colorado, United States
Recruiting
At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
NCT05969860
- Conditions
- Advanced Anal Carcinoma, Advanced Appendix Carcinoma, Advanced Basal Cell Carcinoma, +57 more
- Locations
-
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Altru Cancer Center Grand Forks, North Dakota, United States
Recruiting
Efficacy and Safety oF FErric CarboxymalTose in Patients With Advanced Gastric Cancer(EFFECT-AGC)
NCT05226169
- Conditions
- Advanced Gastric Carcinoma
- Locations
-
- Asan Medical Center Seoul, South Korea
Recruiting
Total Neoadjuvant FLOT Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer
NCT06028737
- Conditions
- Advanced Gastric Adenocarcinoma, Advanced Gastric Carcinoma, Advanced Gastroesophageal Junction Adenocarcinoma, +21 more
- Locations
-
- National Cancer Institute Vilnius, Lithuania
- National Cancer Institute Kyiv, Ukraine
NCT06642857
- Conditions
- Advanced Gastric Carcinoma, Advanced Gastroesophageal Junction Adenocarcinoma
- Locations
-
- Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital) Hangzhou, Zhejiang, China
NCT05620732
- Conditions
- Advanced Gastric Carcinoma, Advanced Pancreatic Carcinoma
- Locations
-
- Li Yu Shenzhen, Guangdong, China
Not Yet Recruiting
SHR-A1811 Combined with Apatinib in the Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma and Colorectal Cancer
NCT06666166
- Conditions
- Advanced Colorectal Cancer, Advanced Gastric Carcinoma, Advanced Gastroesophageal Junction Adenocarcinoma
- Locations
-
- The First Hospital of China Medical University Shenyang, China
Not Yet Recruiting
Study Evaluating Neoadjuvant Immunotherapy Increasing CD8+ Cell Infiltration in Advance Gastric Adenocarcinoma
NCT05270824
- Conditions
- Advanced Gastric Carcinoma, CD8+ Tumor Infiltrating Lymphocytes, Neoadjuvant Immunotherapy
- Locations
-
Not specified
NCT05545293
- Conditions
- Advanced Gastric Carcinoma, Anastomotic Leak, Pathologic Processes, +2 more
- Locations
-
- West China Hospital, Sichuan University Chengdu, Sichuan, China
Completed
Personalized Targeted IMMUNOtherapy-based Regimens in Recurrent GASTric Adenocarcinoma (IMMUNOGAST)
NCT04739202
- Conditions
- Adenocarcinoma, Advanced Gastric Carcinoma, Carcinoma, +13 more
- Locations
-
- Dijon - Centre Georges-Francois Leclerc Dijon, France
- Hcl - Hopital Edouard Herriot Lyon, France
- Aphm - Hopital La Timone Marseille, France
- Aphp - Hopital Saint-Louis Paris, France
Completed
iTTo for Treatment Naive Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
NCT04808791
- Conditions
- Advanced Gastric Carcinoma, Gastroesophageal Junction Adenocarcinoma
- Locations
-
- Cross Cancer Institute Edmonton, Alberta, Canada
NCT05997524
- Conditions
- Advanced Gastric Carcinoma
- Locations
-
- Bangabandhu Sheikh Mujib Medical University Dhaka, Bangladesh
NCT05334849
- Conditions
- Advanced Gastric Carcinoma, Immunotherapy
- Locations
-
- Chinese PLA General Hospital Beijing, Beijing Municipality, China
Completed
A Study of Pemetrexed Plus Oxaliplatin as First Line Therapy in Advanced Gastric Carcinoma
NCT00192088
- Conditions
- Advanced Gastric Carcinoma
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-371-615-4559) Mon - Fri from 9 AM - 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ancona, Italy
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-371-615-4559) Mon - Fri from 9 AM - 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bari, Italy
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-371-615-4559) Mon - Fri from 9 AM - 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bergamo, Italy
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-371-615-4559) Mon - Fri from 9 AM - 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Brescia, Italy
Active, Not Recruiting
Testing the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy With FOLFIRI in Advanced or Metastatic Cancers of the Stomach and Intestines
NCT04535401
- Conditions
- Advanced Colorectal Carcinoma, Advanced Digestive System Carcinoma, Advanced Gastric Carcinoma, +24 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- National Cancer Institute Developmental Therapeutics Clinic Bethesda, Maryland, United States
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
- Siteman Cancer Center at Saint Peters Hospital City of Saint Peters, Missouri, United States
Active, Not Recruiting
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
NCT04704661
- Conditions
- Advanced Breast Carcinoma, Advanced Colon Carcinoma, Advanced Colorectal Carcinoma, +80 more
- Locations
-
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
- Los Angeles General Medical Center Los Angeles, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
Active, Not Recruiting
Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer
NCT04491942
- Conditions
- Adenoma, Adnexal Diseases, Advanced Bile Duct Carcinoma, +72 more
- Locations
-
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- National Cancer Institute Developmental Therapeutics Clinic Bethesda, Maryland, United States
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center New York, United States